Several media have echoed the research project on Friedreich’s Ataxia at IRB Barcelona, funded by the associations of patients and families called the Babel Family and the Asociación Granadina de la Ataxia de Friedreich (ASOGAF), for the initial 18 months.
The project aims to develop an injectable frataxin treatment that can reach the brain. Frataxin is the protein that is reduced in those affected by this rare and degenerative disease, which has no cure.
Link to Canal Sur
Link to EFE Futuro
Link to El Clarín
Link to Heraldo